Skip to content
Back to Guavy Wire
Stocks

GPACTS Convenes Pharma Leaders in Hyderabad for AI, Compliance, and Digital Manufacturing Summit

Instruments
HON
Share

The Global Pharma AI, Compliance & Technology Summit (GPACTS) is gearing up for its Hyderabad edition on September 3, 2026. Powered by Honeywell, this flagship event will bring together around 350-400 senior decision-makers from the pharmaceutical industry to discuss key challenges and opportunities in AI, compliance, and digital manufacturing.

The summit arrives at a critical moment for the pharma sector, which is accelerating investments in artificial intelligence, connected manufacturing, and data-led operations while facing increasing scrutiny on validation, data integrity, cybersecurity, and regulatory compliance. GPACTS will examine how the industry can scale digital transformation without compromising controls required in regulated environments.

Confirmed speakers include Dr. Ajaz Hussain, former FDA Director; Ramanarayana Parhi, Vice President and CIO of Alkem Laboratories; and Praveen Kumar Baheti, Vice President, IT at Biological E. The wider programme will feature leaders from pharmaceutical enterprises, technology organisations, and advisory firms.

The Hyderabad edition is powered by Honeywell and has a confirmed partner ecosystem that includes Rockwell Automation, Nividous Software, Thermo Fisher Scientific, Incep Bio, Abhiyanta Tech & Ample Logic. These organisations strengthen the summit's focus on connected operations, automation, manufacturing intelligence, laboratory and quality systems, enterprise transformation, and emerging pharma technologies.

GPACTS has built a reputation as a practitioner-led platform focused on the intersection of technology, manufacturing, quality, and compliance in regulated pharmaceutical environments. Its events bring together senior decision-makers to exchange implementation experience, examine emerging risks, and discuss priorities shaping pharmaceutical operations.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc